A detailed history of Cedar Mountain Advisors, LLC transactions in Organon & Co. stock. As of the latest transaction made, Cedar Mountain Advisors, LLC holds 50 shares of OGN stock, worth $376. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50
Holding current value
$376
% of portfolio
0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 24, 2025

BUY
$8.4 - $10.85 $420 - $542
50 New
50 $0
Q2 2024

Jul 11, 2024

BUY
$17.45 - $21.96 $69 - $87
4 Added 200.0%
6 $0
Q1 2024

Apr 16, 2024

BUY
$13.78 - $18.8 $27 - $37
2 New
2 $0
Q3 2022

Oct 11, 2022

BUY
$23.4 - $34.25 $23 - $34
1 Added 8.33%
13 $0
Q2 2022

Jul 14, 2022

BUY
$31.66 - $38.9 $379 - $466
12 New
12 $0
Q1 2022

Apr 14, 2022

SELL
$30.45 - $39.36 $365 - $472
-12 Closed
0 $0
Q2 2021

Jul 15, 2021

BUY
$28.45 - $38.0 $341 - $456
12 New
12 $0

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $1.92B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Cedar Mountain Advisors, LLC Portfolio

Follow Cedar Mountain Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cedar Mountain Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cedar Mountain Advisors, LLC with notifications on news.